The chemotherapy and/or radiation given to patients before a stem cell transplant compromise immunity and leave patients vulnerable to infections. This presentation describes major infection risks and effective responses to them. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this presentation possible.

Neuropathy (nerve damage) sometimes occurs after a stem cell transplant. It most often affects hands and feet but can affect other parts of the body as well. This presentation explains what causes neuropathy after transplant and various treatments available to relieve it.

Many transplant recipients experience distress, anxiety, depression and/or post-traumatic stress disorder (PTSD) after transplant. This presentation discusses how to develop coping strategies and resilience to bounce back and experience emotional growth after transplant.

Transplant recipients have an elevated risk of skin problems after transplant that require ongoing surveillance, early detection, and prompt treatment. This presentation describes some of the potential skin problems after transplant, and how to maintain good skin health long-term.

Presenters: Richard Champlin MD, The University of Texas MD Anderson Cancer Center Luke Mountjoy DO, Colorado Blood Cancer Institute, part of the Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s Medical Center Luis Pineiro MD, Baylor, Scott & White/Texas Oncology BMT Program -Dallas

Children who receive bone marrow or stem cell transplant may experience cognitive challenge after treatment. This presentation identifies these challenges, describes how they can be assessed, and suggests school and home-based remedies for these issues.

Medical marijuana offers new options for managing problems arising from cancer treatment. This presentation reviews the potential benefits and risks of cannabis, who is most likely to benefit, and who should avoid using cannabis.

Approximately 60% of patients with chronic graft-versus-host disease (GVHD) have GVHD in their mouth. Patients, as well as dentists, often confuse oral GVHD with other mouth problems. Seeking treatment from a dentist familiar with chronic GVHD is important. Many thanks to Kadmon, a Sanofi Company. whose support, in part, made this presentation possible.

The skin is the most common target of graft-versus-host disease (GVHD), a frequent complication that occurs after a transplant using donor cells. Although most skin changes after transplant are mild or moderate, more severe skin problems are possible.

The way we think and process information can change after transplant, at least in the short-term time. Called cognitive problems, paying attention, concentrating, remembering things and learning new skills can be difficult. This presentation discusses the factors that can cause cognitive problems and strategies to manage them.